Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics in Healthy Subjects”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06086613
What this trial is testing

A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers

Who this might be right for
Osteogenesis Imperfecta
Angitia Incorporated Limited 72
Early research (Phase 1)Study completedNCT01925859
What this trial is testing

EryDex Pharmacokinetics in Healthy Volunteers

Who this might be right for
Healthy
Quince Therapeutics S.p.A. 18
Early research (Phase 1)Study completedNCT02993055
What this trial is testing

Assess Ulimorelin in Healthy Subjects

Who this might be right for
Healthy Subjects
Lyric Pharmaceuticals 39
Early research (Phase 1)Looking for participantsNCT06786676
What this trial is testing

Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants

Who this might be right for
Healthy
Amyloid Solution Inc 88
Early research (Phase 1)Study completedNCT06797674
What this trial is testing

The Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)

Who this might be right for
Healthy
Merck Sharp & Dohme LLC 34
Early research (Phase 1)Study completedNCT05099510
What this trial is testing

Safety and Pharmacokinetics (PK) Study of Natrunix in Healthy Volunteers

Who this might be right for
Pharmacokinetics
XBiotech, Inc. 24
Early research (Phase 1)Study completedNCT02018510
What this trial is testing

A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117

Who this might be right for
HealthyHIV
Rockefeller University 49
Early research (Phase 1)UnknownNCT05499260
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants

Who this might be right for
Healthy Volunteers
Shanghai Zhimeng Biopharma, Inc. 70
Early research (Phase 1)Study completedNCT00761540
What this trial is testing

To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 37
Early research (Phase 1)Study completedNCT03007810
What this trial is testing

Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects

Who this might be right for
Psoriasis
Tianjin Hemay Bio-Tech Co., Ltd 68
Early research (Phase 1)Study completedNCT05226923
What this trial is testing

Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects

Who this might be right for
Bacterial Infections
Sumitovant Biopharma, Inc. 123
Early research (Phase 1)Study completedNCT03849690
What this trial is testing

A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Millennium Pharmaceuticals, Inc. 12
Early research (Phase 1)Study completedNCT06648824
What this trial is testing

Study of How Mitapivat Affects Midazolam Blood Levels in Healthy Participants

Who this might be right for
Healthy Participants
Agios Pharmaceuticals, Inc. 20
Early research (Phase 1)Study completedNCT05275010
What this trial is testing

A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System

Who this might be right for
Healthy Male Subjects
Hoffmann-La Roche 151
Early research (Phase 1)Study completedNCT00362271
What this trial is testing

Aripiprazole and Effexor XR Drug Interaction Study

Who this might be right for
Healthy
Otsuka Pharmaceutical Development & Commercialization, Inc. 38
Early research (Phase 1)Study completedNCT04758234
What this trial is testing

LY3549492 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 54
Early research (Phase 1)Study completedNCT05467709
What this trial is testing

Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects

Who this might be right for
Health Volunteers
Concert Pharmaceuticals 20
Early research (Phase 1)Study completedNCT04894071
What this trial is testing

QA102 Phase 1 Study in Healthy Young and Older Adult Subjects

Who this might be right for
Age-related Macular Degeneration
Smilebiotek Zhuhai Limited 69
Early research (Phase 1)Study completedNCT02341599
What this trial is testing

Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001)

Who this might be right for
Healthy VolunteersRenal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 40
Early research (Phase 1)Study completedNCT00938899
What this trial is testing

TMC435350-TiDP16-C101 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated Dosing

Who this might be right for
Hepatitis C
Tibotec Pharmaceuticals, Ireland 55
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation